Characteristics of surgical prosthetic heart valves and problems around labelling: a document from the European Association for Cardio-Thoracic Surgery (EACTS)– the Society of Thoracic Surgeons (STS)– American Association for Thoracic Surgery (AATS) valve labelling task force

EACTS–STS–AATS Valve Labelling Task Force, Andras P. Durko, Stuart J. Head, Philippe Pibarot, Pavan Atluri, Vinayak Bapat, Duke E. Cameron, Filip P.A. Casselman, Edward P. Chen, Gry Dahle, Tjark Ebels, John A. Elefteriades, Patrizio Lancellotti, Richard L. Prager, Raphael Rosenhek, Alan Speir, Marco Stijnen, Giordano Tasca, Ajit Yoganathan, Thomas Walther & 1 others Ruggero De Paulis

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Intraoperative surgical prosthetic heart valve (SHV) choice is a key determinant of successful surgery and positive postoperative outcomes. Currently, many controversies exist around the sizing and labelling of SHVs rendering the comparison of different valves difficult. To explore solutions, an expert Valve Labelling Task Force was jointly initiated by the European Association for Cardio-Thoracic Surgery (EACTS), The Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS). The EACTS–STS–AATS Valve Labelling Task Force, comprising cardiac surgeons, cardiologists, engineers, regulators and representatives from the International Organization for Standardization (ISO) and major valve manufacturers, held its first in-person meeting in February 2018 in Paris, France. This article was derived from the meeting's discussions. The Task Force identified the following areas for improvement and clarification: reporting of physical dimensions and characteristics of SHVs determining and labelling of SHV size, in vivo and in vitro testing and reporting of SHV hemodynamic performance and thrombogenicity. Furthermore, a thorough understanding of the regulatory background and the role of the applicable ISO standards, together with close cooperation between all stakeholders (including regulatory and standard-setting bodies), is necessary to improve the current situation. Cardiac surgeons should be provided with appropriate information to allow for optimal SHV choice. This first article from the EACTS–STS–AATS Valve Labelling Task Force summarizes the background of SHV sizing and labelling and identifies the most important elements where further standardization is necessary.

LanguageEnglish
Pages292-303
Number of pages12
JournalThe Annals of Thoracic Surgery
Volume108
Issue number1
DOIs
StatePublished - 1 Jul 2019

Fingerprint

Heart Valves
Advisory Committees
Thoracic Surgery
Thorax
Organizations
Paris
France
Hemodynamics
Surgeons

Cite this

@article{be8312d72fe64b789b4e974c9076a663,
title = "Characteristics of surgical prosthetic heart valves and problems around labelling: a document from the European Association for Cardio-Thoracic Surgery (EACTS)– the Society of Thoracic Surgeons (STS)– American Association for Thoracic Surgery (AATS) valve labelling task force",
abstract = "Intraoperative surgical prosthetic heart valve (SHV) choice is a key determinant of successful surgery and positive postoperative outcomes. Currently, many controversies exist around the sizing and labelling of SHVs rendering the comparison of different valves difficult. To explore solutions, an expert Valve Labelling Task Force was jointly initiated by the European Association for Cardio-Thoracic Surgery (EACTS), The Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS). The EACTS–STS–AATS Valve Labelling Task Force, comprising cardiac surgeons, cardiologists, engineers, regulators and representatives from the International Organization for Standardization (ISO) and major valve manufacturers, held its first in-person meeting in February 2018 in Paris, France. This article was derived from the meeting's discussions. The Task Force identified the following areas for improvement and clarification: reporting of physical dimensions and characteristics of SHVs determining and labelling of SHV size, in vivo and in vitro testing and reporting of SHV hemodynamic performance and thrombogenicity. Furthermore, a thorough understanding of the regulatory background and the role of the applicable ISO standards, together with close cooperation between all stakeholders (including regulatory and standard-setting bodies), is necessary to improve the current situation. Cardiac surgeons should be provided with appropriate information to allow for optimal SHV choice. This first article from the EACTS–STS–AATS Valve Labelling Task Force summarizes the background of SHV sizing and labelling and identifies the most important elements where further standardization is necessary.",
author = "{EACTS–STS–AATS Valve Labelling Task Force} and Durko, {Andras P.} and Head, {Stuart J.} and Philippe Pibarot and Pavan Atluri and Vinayak Bapat and Cameron, {Duke E.} and Casselman, {Filip P.A.} and Chen, {Edward P.} and Gry Dahle and Tjark Ebels and Elefteriades, {John A.} and Patrizio Lancellotti and Prager, {Richard L.} and Raphael Rosenhek and Alan Speir and Marco Stijnen and Giordano Tasca and Ajit Yoganathan and Thomas Walther and {De Paulis}, Ruggero",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.athoracsur.2019.03.020",
language = "English",
volume = "108",
pages = "292--303",
journal = "The Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier",
number = "1",

}

Characteristics of surgical prosthetic heart valves and problems around labelling : a document from the European Association for Cardio-Thoracic Surgery (EACTS)– the Society of Thoracic Surgeons (STS)– American Association for Thoracic Surgery (AATS) valve labelling task force. / EACTS–STS–AATS Valve Labelling Task Force ; Stijnen, Marco; De Paulis, Ruggero (Corresponding author).

In: The Annals of Thoracic Surgery, Vol. 108, No. 1, 01.07.2019, p. 292-303.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Characteristics of surgical prosthetic heart valves and problems around labelling

T2 - The Annals of Thoracic Surgery

AU - EACTS–STS–AATS Valve Labelling Task Force

AU - Durko,Andras P.

AU - Head,Stuart J.

AU - Pibarot,Philippe

AU - Atluri,Pavan

AU - Bapat,Vinayak

AU - Cameron,Duke E.

AU - Casselman,Filip P.A.

AU - Chen,Edward P.

AU - Dahle,Gry

AU - Ebels,Tjark

AU - Elefteriades,John A.

AU - Lancellotti,Patrizio

AU - Prager,Richard L.

AU - Rosenhek,Raphael

AU - Speir,Alan

AU - Stijnen,Marco

AU - Tasca,Giordano

AU - Yoganathan,Ajit

AU - Walther,Thomas

AU - De Paulis,Ruggero

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Intraoperative surgical prosthetic heart valve (SHV) choice is a key determinant of successful surgery and positive postoperative outcomes. Currently, many controversies exist around the sizing and labelling of SHVs rendering the comparison of different valves difficult. To explore solutions, an expert Valve Labelling Task Force was jointly initiated by the European Association for Cardio-Thoracic Surgery (EACTS), The Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS). The EACTS–STS–AATS Valve Labelling Task Force, comprising cardiac surgeons, cardiologists, engineers, regulators and representatives from the International Organization for Standardization (ISO) and major valve manufacturers, held its first in-person meeting in February 2018 in Paris, France. This article was derived from the meeting's discussions. The Task Force identified the following areas for improvement and clarification: reporting of physical dimensions and characteristics of SHVs determining and labelling of SHV size, in vivo and in vitro testing and reporting of SHV hemodynamic performance and thrombogenicity. Furthermore, a thorough understanding of the regulatory background and the role of the applicable ISO standards, together with close cooperation between all stakeholders (including regulatory and standard-setting bodies), is necessary to improve the current situation. Cardiac surgeons should be provided with appropriate information to allow for optimal SHV choice. This first article from the EACTS–STS–AATS Valve Labelling Task Force summarizes the background of SHV sizing and labelling and identifies the most important elements where further standardization is necessary.

AB - Intraoperative surgical prosthetic heart valve (SHV) choice is a key determinant of successful surgery and positive postoperative outcomes. Currently, many controversies exist around the sizing and labelling of SHVs rendering the comparison of different valves difficult. To explore solutions, an expert Valve Labelling Task Force was jointly initiated by the European Association for Cardio-Thoracic Surgery (EACTS), The Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS). The EACTS–STS–AATS Valve Labelling Task Force, comprising cardiac surgeons, cardiologists, engineers, regulators and representatives from the International Organization for Standardization (ISO) and major valve manufacturers, held its first in-person meeting in February 2018 in Paris, France. This article was derived from the meeting's discussions. The Task Force identified the following areas for improvement and clarification: reporting of physical dimensions and characteristics of SHVs determining and labelling of SHV size, in vivo and in vitro testing and reporting of SHV hemodynamic performance and thrombogenicity. Furthermore, a thorough understanding of the regulatory background and the role of the applicable ISO standards, together with close cooperation between all stakeholders (including regulatory and standard-setting bodies), is necessary to improve the current situation. Cardiac surgeons should be provided with appropriate information to allow for optimal SHV choice. This first article from the EACTS–STS–AATS Valve Labelling Task Force summarizes the background of SHV sizing and labelling and identifies the most important elements where further standardization is necessary.

UR - http://www.scopus.com/inward/record.url?scp=85067501046&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2019.03.020

DO - 10.1016/j.athoracsur.2019.03.020

M3 - Article

VL - 108

SP - 292

EP - 303

JO - The Annals of Thoracic Surgery

JF - The Annals of Thoracic Surgery

SN - 0003-4975

IS - 1

ER -